Full-Time

Senior Vice President

Strategy

Biolumina

Biolumina

201-500 employees

Global healthcare branding through science translation

Compensation Overview

$180k - $266.5k/yr

New York, NY, USA

In Person

Category
Business & Strategy (1)
Requirements
  • 10 years’ experience in pharmaceutical marketing and/or strategy consulting in pharmaceuticals/healthcare or pharmaceutical advertising agency experience
  • In person client travel is required
  • Strong presentation and moderation skills and exceptional PowerPoint storytelling capabilities
Responsibilities
  • Monitor the pharmaceutical/biotech industry in general, as well as oncology specifically, and be able to rapidly communicate trends and business opportunities to colleagues and clients
  • Understands and accesses available tools and data resources; recommends tools that would expand agency capabilities
  • Understand beliefs (rational and emotional) of the target audiences (HCPs and patients) as well as drivers and barriers of behavior, and identify leverage points for change
  • Demonstrate primary and secondary research capabilities, knowledge of market research design methodology, and ability to interpret results
  • Design customized workshops (eg, positioning, messaging, competitive analysis) and dynamically lead facilitation
  • Develop strategic deliverables that include but are not limited to: competitive analysis; brand positioning; creative core idea; market research synthesis, creative brief, workshops (activities and output reports), and brand plans
  • Experience with oncology brands (preferred)
  • In person client travel is required
  • Strong presentation and moderation skills and exceptional PowerPoint storytelling capabilities
Desired Qualifications
  • Experience with oncology brands (preferred)

Biolumina is a full-service, global healthcare agency that brings high-science brands to life through omnichannel marketing. It builds brand experiences that go beyond data and use emotional hooks to motivate action, change behavior, and foster brand loyalty. By acting as translational scientists, Biolumina translates complex scientific ideas into clear, compelling creative and brand stories, driven by curiosity and deep customer insights. The company differentiates itself with a strong emphasis on translating scientific content into engaging, emotionally resonant experiences at scale, serving as a partner for high-science brands across channels. Its goal is to move the needle for clients by turning scientific concepts into motivating narratives that change behavior and build long-term loyalty.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Rock Island, Illinois

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Added clients Bicycle Therapeutics, Nuvation Bio, Zentalis Pharmaceuticals in 2024.
  • Headcount grew from 425 to 475 supporting steady organic growth.
  • On target for healthy 2025 business with new wins per CEO Kantak.

What critics are saying

  • Oncology patent cliffs hit Keytruda in 2028, Opdivo in 2026, concentrating revenue.
  • Merck-Seagen 2023 integration cuts client brand teams and agency needs.
  • Omnicom merges redundant agencies, pressuring Biolumina post-2024 Rise & Run buy.

What makes Biolumina unique

  • Biolumina specializes exclusively in oncology marketing as its core superpower.
  • Integrated Rise & Run team enhances customized data-driven healthcare solutions.
  • Omnicom Health Group resources enable omnichannel global advertising expertise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Company News

Haymarket Media
Sep 4th, 2024
Imre hires Ben Bromberg and Brett Courtright to boost media, medical services

Bromberg brings 15 years of media experience to Imre, while Courtright joins from Biolumina.

PharmaLive
Apr 21st, 2023
Med Ad News announces winners of 34th annual Manny Awards – PharmaLive

Following another year of record-setting growth, Biolumina Group was awarded Agency of the Year Category II (agencies with annual revenue between $25 million and $100 million).